Showing results 3157 to 3176 of 3323
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2009 | Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society | Moran, L.; Pasquali, R.; Teede, H.; Hoeger, K.; Norman, R. |
| 2001 | Treatment of preterm labor with the oxytocin antagonist atosiban: a double-bind, randomized, controlled comparison with salbutamol | Cabrol, D.; Gillett, J.; Madelenat, P.; Lansac, J.; Paniel, B.; Dellenbach, P.; Lemoine, J.; Bronstein, R.; Leng, J.; Laurent, M.; Mares, P.; Hedon, B.; Magnin, G.; Treisser, A.; Schumacher, J.; Grosieux, P.; Jacquetin, P.; Bruhat, M.; Segard, L.; Puech, F.; et al. |
| 2012 | Treatment should be considered a competing risk when predicting natural conception in subfertile women | Van Geloven, N.; Broeze, K.; Bossuyt, P.; Zwinderman, A.; Mol, B. |
| 2017 | Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis | Wang, R.; Kim, B.; Van Wely, M.; Johnson, N.; Costello, M.; Zhang, H.; Ng, E.; Legro, R.; Bhattacharya, S.; Norman, R.; Mol, B. |
| 2015 | Trends in birth asphyxia, obstetric interventions and perinatal mortality among term singletons: a nationwide cohort study | Ensing, S.; Abu-Hanna, A.; Schaaf, J.; Mol, B.; Ravelli, A. |
| 2004 | Trends in place of birth for preterm infants in New South Wales, 1992-2001 | Roberts, C.; Algert, C.; Peat, B.; Henderson-Smart, D. |
| 2020 | Trends in preterm birth in singleton and multiple gestations in the Netherlands 2008-2015: a population-based study | van Zijl, M.D.; Koullali, B.; Oudijk, M.A.; Ravelli, A.C.J.; Mol, B.W.J.; Pajkrt, E.; Kazemier, B.M. |
| 2021 | Trends in preterm birth in twin pregnancies in Victoria, Australia, 2007–2017 | Burger, R.J.; Temmink, S.; Wertaschnigg, D.; Ganzevoort, W.; Reddy, M.; Davey, M.A.; Wallace, E.M.; Mol, B.W. |
| 2011 | Trends in preterm birth: singleton and multiple pregnancies in The Netherlands, 2000-2007 | Schaaf, J.M.; Mol, B.W.; Abu Hanna, A.; Ravelli, A.C.; 30th Annual Meeting of the Society-for-Maternal-Fetal-Medicine (1 Feb 2010 - 6 Feb 2010 : Chicago, IL) |
| 2011 | Trends in preterm birth: singleton and multiple pregnancies in the Netherlands, 2000-2007 | Schaaf, J.; Mol, B.; Abu-Hanna, A.; Ravelli, A. |
| 2021 | Trends in singleton preterm birth in Victoria, 2007 to 2017: a consecutive cross-sectional study | Burger, R.J.; Temmink, J.D.; Wertaschnigg, D.; Ganzevoort, W.; Reddy, M.; Davey, M.-A.; Wallace, E.M.; Mol, B.-W. |
| 2013 | Trial designs for personalizing cancer care: a systematic review and classification | Tajik, P.; Zwinderman, A.; Mol, B.; Bossuyt, P. |
| 2006 | Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages | Haynes, C.; Ryan, N.; Van Der Hoek, K.; Robker, R.; Norman, R. |
| 1995 | Trophic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos | Lavranos, Tina C.; Rathgen, P. D.; Seamark, Robert F. |
| 2019 | “Trying to give birth naturally was out of the question”: Accounting for intervention in childbirth | Cole, L.; LeCouteur, A.; Feo, R.; Dahlen, H. |
| 2013 | Tubal factor infertility and perinatal risk after assisted reproductive technology | Kamphuis, E.I.; Hermans, F.J.R.; Mol, B.W.J. |
| 2020 | Tubal factor infertility with prior ectopic pregnancy: a double whammy? A retrospective cohort study of 2,892 women | Cai, H.; Mol, B.W.; Li, P.; Liu, X.; Watrelot, A.; Shi, J. |
| 2019 | Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit? | van Rijswijk, J.; van Welie, N.; Dreyer, K.; Tajik, P.; Lambalk, C.B.; Hompes, P.; Mijatovic, V.; Mol, B.W.J.; Zafarmand, M.H. |
| 1995 | Tubal microendoscopy, salpingoscopy and falloposcopy | Kerin, John Francis Paul; Pearlstone, A. J.; Surrey, E. S. |
| 2011 | Tubal surgery before IVF | Johnson, N.; van Voorst, S.; Sowter, M.; Strandell, A.; Mol, B. |
